ANTI-DKK-1-ANTI-RANKL BISPECIFIC ANTIBODY COMPOUNDS

• 收藏
• 分享

专利权人:

Eli Lilly and Company

发明人:

Victor H Obungu,Andrew Korytko

申请号：

US15570756

公开号：

US20180118840A1

申请日:

2016.05.12

申请国别(地区):

US

年份:

2018

代理人:

摘要：

Bispecific antibody compounds, and methods of using same, are provided which bind and neutralize Dkk-1 and RANKL and which are useful as adjuncts to spinal fusion surgery or as agents for bone healing or treating conditions associated with bone loss or degeneration.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/